mercredi 26 novembre 2014

Experimental Ebola vaccine appears safe, prompts immune response

An experimental vaccine to prevent Ebola virus disease was well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial.

Experimental Ebola vaccine appears safe, prompts immune response

Aucun commentaire:

Enregistrer un commentaire